Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

AIMS: This study aimed to assess safety and cardiovascular outcomes of dronedarone in patients with paroxysmal or persistent atrial fibrillation (AF) with coronary heart disease (CHD). Coronary heart disease is prevalent among AF patients and limits antiarrhythmic drug use because of their potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisters, Ron, Hohnloser, Stefan H., Connolly, Stuart J., Torp-Pedersen, Christian, Naditch-Brûlé, Lisa, Page, Richard L., Crijns, Harry J.G.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905706/
https://www.ncbi.nlm.nih.gov/pubmed/24072451
http://dx.doi.org/10.1093/europace/eut293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905706/
https://www.ncbi.nlm.nih.gov/pubmed/24072451
http://dx.doi.org/10.1093/europace/eut293

Ejemplares similares